# | ||||
---|---|---|---|---|
1 | ADAMANT ANTIBODY DERIVATIVES AS MOLECULAR AGENTS FOR NEOPLASTIC TARGETING | 2008 | 3˙918˙400.00 | 3˙000˙000.00 |
2 | ARCH Patient specific image-based computational modelling for nimprovement of short- and long-term outcome of vascular access nin patient on hemodialysis therapy | 2008 | 5˙716˙740.00 | 3˙759˙499.00 |
3 | ORCHESTRA "Organising dissemination on Results of projects on Chemical Evaluation, Spreading Techniques for Risk Assessment" | 2009 | 1˙048˙762.00 | 910˙929.00 |
4 | TOXBANK ToxBank – Supporting Integrated Data Analysis and Servicing of Alternative Testing Methods in Toxicology | 2011 | 3˙129˙992.00 | 1˙564˙996.00 |
5 | COHEMI Coordinating resources to assess and improve health status of migrants from Latin America | 2011 | 2˙271˙341.00 | 1˙999˙959.00 |
6 | RESET Dreaming of no more renal dialysis: how self-derived tissue and cells can replace renal function | 2011 | 2˙493˙000.00 | 2˙493˙000.00 |
7 | MUSCLEANDCANCER Search for novel molecules cross-talking between muscle and cancer with therapeutic potential against cachexia and cancer | 2012 | 100˙000.00 | 100˙000.00 |
8 | ECRAN European Communication on Research Awareness Needs | 2012 | 970˙625.00 | 892˙666.00 |
9 | CREACTIVE Collaborative REsearch on ACute Traumatic brain Injury in intensiVe care medicine in Europe | 2013 | 7˙032˙384.00 | 5˙443˙350.00 |
L'Ente istituto di ricerche farmacologiche mario negri partecipato anche in questi progetti.